REGN PEER ANALYSIS

Regeneron Pharmaceuticals Inc — metric-by-metric comparison with peers and the industry median

REGNRegeneron Pharmaceuticals Inc

🇺🇸 USA · US · Healthcare · Biotechnology

Value it Duel

Overall Profile & Returns

· Biotechnology

Position Within Industry

0 = weak quartile, 100 = strong quartile

REGNIndustry median

Scores normalize each metric against industry quartiles (p25–p75); direction is inverted for lower-is-better metrics.

Return Comparison

1-Year

Split-adjusted

Year-to-Date (YTD)

Key Metric Comparison

P/E

Lower is better

ROE

Higher is better

Net Margin

Higher is better

Revenue Growth

Higher is better

All Metrics

Valuation
Metric	REGN	CSL	TLX	Ind. Median
P/E	16.14●	30.04	—	18.00
P/B	2.27	2.25●	6.26	3.60
EV/EBITDA	11.37	10.37●	118.24	15.20
P/S	4.79	2.67●	3.18	10.43

Financial Health
Metric	REGN	CSL	TLX	Ind. Median
Current Ratio	3.57●	2.57	1.43	5.90
Debt/Equity	8.6%●	67.4%	112.3%	10.9%
NetDebt/EBITDA	-1.05●	2.22	13.13	1.15

Profitability
Metric	REGN	CSL	TLX	Ind. Median
Net Margin	29.6%●	9.2%	-0.9%	-125.7%
ROE	14.5%●	7.7%	-1.8%	-47.5%
ROA	11.3%●	3.8%	-0.7%	-35.8%
EBITDA Margin	38.5%●	32.8%	3.0%	-105.8%

Growth + Dividend
Metric	REGN	CSL	TLX	Ind. Median
Rev. Growth	5.9%	4.8%	56.3%●	5.1%
NI Growth	-1.7%●	-39.4%	—	12.1%
Div. Yield	0.6%	2.5%●	—	0.2%
Payout	8.5%	103.1%	—	0.0%

Valuation
Metric	REGN	ALNY	RVMD	VRTX	RPRX	MRNA	Ind. Median
P/E	16.14●	77.47	—	29.45	39.47	—	18.00
P/B	2.27●	41.58	25.06	6.60	4.74	3.94	3.60
EV/EBITDA	11.37●	46.49	—	22.72	24.14	—	15.20
P/S	4.79●	10.43	—	10.42	13.38	13.10	10.43

Financial Health
Metric	REGN	ALNY	RVMD	VRTX	RPRX	MRNA	Ind. Median
Current Ratio	3.57	3.13	6.80●	3.02	2.66	2.41	5.90
Debt/Equity	8.6%●	118.4%	29.2%	10.3%	130.0%	17.5%	10.9%
NetDebt/EBITDA	-1.05	-1.88●	1.12	-0.98	4.91	1.35	1.15

Profitability
Metric	REGN	ALNY	RVMD	VRTX	RPRX	MRNA	Ind. Median
Net Margin	29.6%	13.5%	—	35.4%●	33.9%	-143.6%	-125.7%
ROE	14.5%	96.9%●	-76.7%	24.2%	12.2%	-36.6%	-47.5%
ROA	11.3%	12.4%	-59.4%	17.6%●	4.4%	-26.4%	-35.8%
EBITDA Margin	38.5%	21.6%	—	44.0%	69.6%●	-129.7%	-105.8%

Growth + Dividend
Metric	REGN	ALNY	RVMD	VRTX	RPRX	MRNA	Ind. Median
Rev. Growth	5.9%	82.6%●	-100.0%	10.4%	7.8%	-29.1%	5.1%
NI Growth	-1.7%●	—	—	—	-24.3%	—	12.1%
Div. Yield	0.6%	—	—	—	1.6%●	—	0.2%
Payout	8.5%	—	—	—	46.8%	—	0.0%

The green dot marks the best value in the group given the metric direction (higher/lower is better). All metrics use trailing-twelve-month (TTM) data.

Go deeper on REGN

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Jul 8, 26. This content is for informational purposes only and is not investment advice.